A. Semke

[An effect of quetiapine on the immune system of patients with schizophrenia].

N. Bokhan, T. Vetlugina, O. Lobacheva, 2016, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

Adjunctive use of interferon γ inducer for treatment of patients with schizophrenia

T. Nevidimova, T. Vetlugina, S. Sergeeva, 2015, Acta Neuropsychiatrica.

Relationship Between Social Adaptation Self-Evaluation and Suicide Risk in Patients with Schizophrenia

E. Kornetova, A. Goncharova, A. Kornetov, 2021, Psikhiatriya.

Opening up new horizons for psychiatric genetics in the Russian Federation: moving toward a national consortium

T. Schulze, R. Gainetdinov, E. Khusnutdinova, 2019, Molecular Psychiatry.

Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of CHRM1 and CHRM2 muscarinic receptors

N. Bokhan, M. Freidin, B. Wilffert, 2019, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Clozapine.

D. Cohen, J. Kosterink, N. Bokhan, 2017, The Journal of clinical psychiatry.

Influence of clinical and therapeutic indicators on the severity of neurocognitive deficits in patients with schizophrenia

E. Kornetova, A. Goncharova, A. Kornetov, 2020, Bulletin of Siberian Medicine.